Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis

Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis

Abstract Background The clinical efficacy of rupatadine in terms of responders has not been previously explored in perennial allergic rhinitis (PAR). Methods This pooled analysis included data from 6 randomised, double-blind, placebo-controlled trials conducted in PAR patients treated with rupatadin...

Full description

Bibliographic Details
Main Authors: Antonio Valero, Iñaki Izquierdo, Marek L. Kowalski, Glenis K. Scadding, Jean Bousquet, Joaquim Mullol
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
PAF antagonist
Perennial allergic rhinitis
Responder analysis
Rupatadine
Second-generation H1-antihistamines
Online Access:http://link.springer.com/article/10.1186/s13223-020-00425-1

Internet

http://link.springer.com/article/10.1186/s13223-020-00425-1

Similar Items